Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 401 to 450 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
401\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenylate cyclase, type v (ec 4.6.1.1) (atp pyrophosphate-lyase) (adenylyl cyclase) (fragment). [source:swissprot;acc:o95622]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5201.41\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4479.76\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.16109\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
402\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat-containing protein 15 precursor (hlib). [source:swissprot;acc:q8tf66]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
403\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fem-1 homolog b; fem-1-like death receptor binding protein; fem-1 (c.elegans) homolog b. [source:refseq;acc:nm\_015322]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
404\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat protein lrrc3 precursor. [source:swissprot;acc:q9by71]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
405\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
laminin gamma-1 chain precursor (laminin b2 chain). [source:swissprot;acc:p11047]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
406\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
thymic stromal co-transporter. [source:refseq;acc:nm\_033051]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
407\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein interacting protein (wasp interacting protein) (prpl-2 protein). [source:swissprot;acc:o43516]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6603.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7664.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16071\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dok-like protein. [source:refseq;acc:nm\_024872]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6102.59\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7081.46\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.1604\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 2 (p56(dok-2)) (downstream of tyrosine kinase 2). [source:swissprot;acc:o60496]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
410\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
docking protein 1 (p62(dok)) (downstream of tyrosine kinase 1) (pp62). [source:swissprot;acc:q99704]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tyrosine-protein kinase frk (ec 2.7.1.112) (nuclear tyrosine protein kinase rak). [source:swissprot;acc:p42685]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mki67 (fha domain) interacting nucleolar phosphoprotein; nucleolar phosphoprotein nopp34; nucleolar protein interacting with the fha domain of pki-67. [source:refseq;acc:nm\_032390]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3594.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4169.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.16015\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
413\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vav proto-oncogene. [source:swissprot;acc:p15498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6644.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7707.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15994\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
414\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
autophagy protein 5-like (apg5-like) (apoptosis-specific protein). [source:swissprot;acc:q9h1y0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6744.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5815.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15974\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
415\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vav-3 protein. [source:swissprot;acc:q9ukw4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6647.43\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7706.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15927\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
416\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
n-terminal acetyltransferase complex ard1 subunit homolog (ec 2.3.1.-). [source:swissprot;acc:p41227]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4509.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5223.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15842\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
417\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bag-family molecular chaperone regulator-3 (bcl-2 binding athanogene- 3) (bag-3) (bcl-2-binding protein bis) (docking protein cair-1). [source:swissprot;acc:o95817]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4522.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5233.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15708\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
418\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast carcinoma amplified sequence 2; spliceosome associated protein, amplified in breast cancer. [source:refseq;acc:nm\_005872]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5493.1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6350.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.15603\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
419\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdc5-like; cdc5 (cell division cycle 5, s. pombe, homolog)-like; cell division cycle 5, s. pombe, homolog-like; cdc5-related protein. [source:refseq;acc:nm\_001253]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
420\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hypoxanthine-guanine phosphoribosyltransferase (ec 2.4.2.8) (hgprt) (hgprtase). [source:swissprot;acc:p00492]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10235.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11830.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15589\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
421\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vav-2 protein. [source:swissprot;acc:p52735]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6660.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7697.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15582\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
422\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 5 (tap-like protein 1) (tapl-1). [source:swissprot;acc:q9h1b4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5206.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6010.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15425\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 3 (tap-like protein 3) (tapl-3). [source:swissprot;acc:q9h4d5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5207.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6010.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15423\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
424\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 1 (tip associating protein) (tip-associated protein) (mrna export factor tap). [source:swissprot;acc:q9ubu9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5207.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6010.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15413\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
425\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
saccharomyces cerevisiae nip7p homolog. [source:refseq;acc:nm\_016101]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3729.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4301.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15354\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
426\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pef protein with a long n-terminal hydrophobic domain (peflin). [source:refseq;acc:nm\_012392]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5942.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6853.15\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15325\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
427\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trna (5-methylaminomethyl-2-thiouridylate)-methyltransferase (ec 2.1.1.61). [source:swissprot;acc:o75648]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11736.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13531.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15297\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
428\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar gtp-binding protein 1 (chronic renal failure gene protein) (gtp-binding protein ngb). [source:swissprot;acc:q9bze4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3721.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4288.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15237\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
429\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vinexin (sh3-containing adaptor molecule-1) (scam-1). [source:swissprot;acc:o60504]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6272.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7226.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15195\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
430\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor dp-2 (e2f dimerization partner 2). [source:swissprot;acc:q14188]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3804.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4379.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15123\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
431\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 31 isoform 1; dead/dexh helicase ddx31. [source:refseq;acc:nm\_022779]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3849.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4431.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15102\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
432\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial processing peptidase beta subunit, mitochondrial precursor (ec 3.4.24.64) (beta-mpp) (p-52). [source:swissprot;acc:o75439]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5244.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6036.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15093\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
433\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mitochondrial processing peptidase alpha subunit, mitochondrial precursor (ec 3.4.24.64) (alpha-mpp) (p-55) (ha1523). [source:swissprot;acc:q10713]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5244.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6036.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15091\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
434\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquinol-cytochrome c reductase complex core protein i, mitochondrial precursor (ec 1.10.2.2). [source:swissprot;acc:p31930]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5246.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6037.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15077\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
435\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proline synthetase co-transcribed bacterial homolog protein. [source:swissprot;acc:o94903]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5233.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6022.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1507\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
436\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arg/abl-interacting protein 2 isoform 2; arg binding protein 2. [source:refseq;acc:nm\_021069]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6230.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7168.2\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.15042\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
437\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
suppressor of swi4 1 homolog (ssf-1) (peter pan homolog). [source:swissprot;acc:q9nq55]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3779.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4348.48\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
438\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
swi/snf-related, matrix-associated, actin-dependent regulator of chromatin subfamily f member 1 (swi-snf complex protein p270) (b120). [source:swissprot;acc:o14497]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6252.58\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7192.88\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.15039\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
439\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
programmed cell death protein 6 (probable calcium-binding protein alg- 2). [source:swissprot;acc:o75340]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
440\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcium-dependent protease, small subunit (calpain regulatory subunit) (calcium-activated neutral proteinase) (canp). [source:swissprot;acc:p04632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6251.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7192.08\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.15038\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
441\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
grancalcin. [source:swissprot;acc:p28676]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6251.96\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7192.13\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
442\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorcin (22 kda protein) (cp-22) (v19). [source:swissprot;acc:p30626]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6251.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7192.17\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
443\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
brg1-binding protein eld/osa1; eld (eyelid)/osa protein. [source:refseq;acc:nm\_020732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6252.27\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7192.51\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
444\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable rrna processing protein ebp2 (ebna1 binding protein 2) (nucleolar protein p40). [source:swissprot;acc:q99848]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3758.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4322.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15011\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
445\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ad24 protein. [source:refseq;acc:nm\_022451]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3753.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4315.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14978\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
446\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleostemin; putative nucleotide binding protein, estradiol-induced. [source:refseq;acc:nm\_014366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3766.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4329.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14958\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
447\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pescadillo homolog 1. [source:swissprot;acc:o00541]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3751.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4310.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14922\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
448\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ponsin; sh3-domain protein 5 (ponsin). [source:refseq;acc:nm\_015385]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6259.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7190.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14884\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
449\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
wd-repeat protein 12 (ytm1 homolog). [source:swissprot;acc:q9gzl7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3761.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4319.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14837\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
450\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
l-myc-1 proto-oncogene protein. [source:swissprot;acc:p12524]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4889.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5610.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14753\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/